Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Cut by Klingenstein Fields & Co. LP

Klingenstein Fields & Co. LP cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 83,903 shares of the medical equipment provider's stock after selling 1,142 shares during the period. Intuitive Surgical comprises approximately 1.8% of Klingenstein Fields & Co. LP's holdings, making the stock its 16th biggest position. Klingenstein Fields & Co. LP's holdings in Intuitive Surgical were worth $43,794,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of ISRG. V Square Quantitative Management LLC grew its holdings in shares of Intuitive Surgical by 4.5% during the fourth quarter. V Square Quantitative Management LLC now owns 3,680 shares of the medical equipment provider's stock valued at $1,921,000 after purchasing an additional 157 shares during the last quarter. First Merchants Corp bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $201,000. Compagnie Lombard Odier SCmA grew its stake in Intuitive Surgical by 46.1% during the 4th quarter. Compagnie Lombard Odier SCmA now owns 3,775 shares of the medical equipment provider's stock worth $1,970,000 after buying an additional 1,192 shares during the last quarter. Root Financial Partners LLC grew its stake in Intuitive Surgical by 3.4% during the 4th quarter. Root Financial Partners LLC now owns 3,630 shares of the medical equipment provider's stock worth $1,895,000 after buying an additional 121 shares during the last quarter. Finally, Vontobel Holding Ltd. increased its position in Intuitive Surgical by 5.8% in the fourth quarter. Vontobel Holding Ltd. now owns 48,776 shares of the medical equipment provider's stock worth $25,459,000 after buying an additional 2,655 shares during the period. Institutional investors own 83.64% of the company's stock.

Remove Ads

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the company's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the firm's stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company's stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is owned by insiders.

Intuitive Surgical Trading Up 0.7 %

Shares of NASDAQ ISRG traded up $4.16 during midday trading on Monday, reaching $595.55. The company's stock had a trading volume of 1,188,781 shares, compared to its average volume of 1,979,754. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a market cap of $212.12 billion, a price-to-earnings ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. The company has a 50 day moving average price of $559.48 and a 200 day moving average price of $520.19.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ISRG shares. BTIG Research boosted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a report on Tuesday, November 26th. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Finally, Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.